Myeloma UK welcomes two new trustees

Myeloma UK is delighted to announce the appointment of two trustees.

As the newest members of the Board of Trustees, Rachel Snow-Miller and Deb Lancaster are both eager to harness their decades of experience in the NHS and pharmaceutical industry respectively to address health inequalities and spearhead change for the myeloma community.

Rachel was moved to join Myeloma UK after being diagnosed with blood cancer and facing lengthy delays in diagnosis.

“As someone with lived experience of being diagnosed with a blood cancer after a delayed diagnosis and having to really fight to get that diagnosis, to get to the right haematologist even, and to get medication for my treatment, I felt a real connection to the organisation,” said Rachel, a senior leader in the NHS. “Myeloma UK is a small charity that’s doing so much and is really punching high and hard above its weight. That power is something that I’m proud to be part of.

“I have a background working with people from deprived communities and people who are less able to advocate for themselves and I want to put it to good use to help make sure we, as an organisation, are here for everyone with myeloma.”

Deb spent 30 years in the pharmaceutical industry, most recently as Market Access Director at Roche and Novartis specialising in oncology, before taking on her current role as Service Owner at Genomics England Ltd.

She said: “Myeloma UK’s work is second to none. I’ve worked with patient advocacy groups for most of my career and most of them tend to focus on one area: funding research, doing research, supporting patients or policy work and lobbying. But Myeloma UK runs the whole gamut, and its patient support and policy and access work have been an absolute game-changer.

“I’ve always been really passionate about making sure that cancer patients get the treatments that they deserve and I’m very keen to help Myeloma UK make a difference.”

Dr Sophie Castell, Chief Executive at Myeloma UK, said: “I would like to extend a warm welcome to Rachel and Deb. Their shared passion for improving people’s lives no matter their background and decades-long fight to tackle inequalities, break down barriers to healthcare and treatment perfectly align with our ambitions and values. With their help and insights, we will achieve our goal to support more people and make sure no one faces myeloma alone.”

Close-up photograph of a hand holding a mobile phone.

Stay in touch

We’d love to stay in touch. Join our mailing list to receive updates from Myeloma UK including our monthly newsletter and updates about our services, research, campaigns and other ways you can get involved.